6 unknown. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 1 | 1 | Unknown 1 |
Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill, Intensity-modulated radiotherapy - Nasopharyngeal Carcinoma, Iron-deficiency | Phase 2 | Unknown | Sun Yat-sen University | 120 | 2023-05-05 | 2023-06-22 |
| Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy Triferic AVNU, Placebo - Iron Deficiency Anemia | Phase 2 | Unknown | Rockwell Medical Technologies, Inc. | 75 | 2021-11-30 | 2021-11-08 |
| Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Ferrous succinate - Vascular Cognitive Impairment, Dementia, Vascular | Phase 2 | Unknown | Beijing Tiantan Hospital | 1006 | 2019-04-01 | 2020-07-13 |
| Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia Buxue Yimu Pills, Buxue Yimu Pills &Ferrous Sulfate, Ferrous Sulfate - Iron-Deficiency Anemia | Phase 2 | Unknown | Peking Union Medical College Hospital | 180 | 2017-06-01 | 2018-02-13 |
| Fermented Iron-rich Supplement in Reducing Anemia supplement containing 60 mg iron sulfate, iron rich food supplement (60 mg iron), iron rich food supplement (10 mg iron) - Iron Deficiency Anemia | Phase 2 | Unknown | University of Ghana | 120 | 2014-03-01 | 2014-01-16 |
| Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure Venofer (intravenous iron sucrose) - Chronic Heart Failure, Heart Diseases | Phase 1 / Phase 2 | Unknown | National Heart and Lung Institute | 42 | 2004-07-01 | 2005-08-17 |
Anemia, Iron-Deficiency (6) · Anemia (2) · Iron Deficiencies (2) · Cerebral Infarction (1) · Dementia (1) · Dementia, Vascular (1) · Heart Diseases (1) · Nasopharyngeal Carcinoma (1)
Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Iron Metabolism Disorders (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Anemia (4) · Iron Deficiencies (4) · Cardiovascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Brain Diseases (1) · Brain Infarction (1) · Brain Ischemia (1) · Carcinoma (1)
Iron-Dextran Complex (2) · Ferric Oxide, Saccharated (1) · Iron (1) · Niferex (1) · Radiotherapy, Intensity-Modulated (1) · ferrous succinate (1) · ferrous sulfate (1) · iron isomaltoside 1000 (1) · spleen fibrinolytic proteinase (human) (1)
Beijing Tiantan Hospital (1) · National Heart and Lung Institute (1) · Peking Union Medical College Hospital (1) · Rockwell Medical Technologies, Inc. (1) · Sun Yat-sen University (1) · University of Ghana (1)
China (3) · Poland (1) · United Kingdom (1)
Aijun AJ Sun, MD (1) · Jia Qian, doctor (1) · Manju Reddy, PhD (1) · Philip A Poole-Wilson, MD,FRCP (1) · Raymond D Pratt, MD, FACP (1) · Richmond Aryeetey, PhD (1) · Shan Shan Guo, Dr (1)
PMID 18191732, PMID 28029503, PMID 28487769, PMID 34241801, PMID 38789134